Feedback PLC Selected for Digitalhealth.London 2020 Programme
10 November 2020 - 10:06AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
10 November 2020
Feedback plc
Bleepa selected for Digitalhealth.London 2020 Accelerator
Programme
-- 12 month programme to support the pioneering of digital innovations by the NHS
-- Dedicated support by NHS Expert to showcase innovations in health facilities
-- Improves market access and NHS navigation to scale digital
products across the health and care sector in London
London, 10 November 2020: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist medical imaging technology company,
today announces that Bleepa has been selected for
DigitalHealth.London's 2020 12 month accelerator programme to
promote innovative technologies to London NHS hospitals.
DigitalHealth.London
DigitalHealth.London's Accelerator programme aims to speed up
the adoption of technology within London's NHS, relieving high
pressure on services and empowering patients to manage their
health.
Now in its fifth consecutive year, the DigitalHealth.London
Accelerator works with up to 20 high potential SMEs over a 12-month
period, giving bespoke support and advice, a programme of
expert-led workshops and events, and brokering meaningful
connections between innovators and NHS organisations with specific
challenges. Each SME is assigned an NHS Navigator, an experienced
professional from the NHS with the expertise to share advice on
products in development, NHS navigation and business models.
Dr Tom Oakley, CEO of Feedback, commented:
"DigitalHealth.London is a targeted accelerator for London
hospitals with a focus to scan the horizon for the very best of new
innovative healthcare technologies, which it then showcases to
London-based hospitals. It has an extremely rigorous selection
process and we are delighted that Bleepa has been chosen as part of
the 2020 offering. For us, this is an important opportunity to
really get in front of the London hospital network to show them
what Bleepa can do, how it can revolutionise their imaging
communications and ultimately, why they should choose Bleepa."
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint
Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited
(Joint Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
DigitalHealth.London
DigitalHealth.London is helping health tech entrepreneurs and
healthcare professionals turn the idea of digital innovation into
tangible improvements for staff and patients.
Our initiatives bring together health and care stakeholders
across London to collaborate and solve some of the biggest
challenges in the NHS.
DigitalHealth.London is a collaborative programme delivered by
MedCity , and London's three Academic Health Science Networks - UCL
Partners , Imperial College Health Partners and the Health
Innovation Network .
It is supported by NHS England (London) and the Mayor's Office.
The DigitalHealth.London Accelerator is supported by the additional
partner, CW+ , and is part-funded through the European Regional
Development Fund.
https://digitalhealth.london/about/
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABMBLTMTMBMAM
(END) Dow Jones Newswires
November 10, 2020 04:06 ET (09:06 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024